glp 1 excessive gas Your guide to GLP-1 side effects Clinical Recommendations to Manage Gastrointestinal

4 Of the two dominant incretins, GIP has been shown to have a greater effect on insulin release following oral glucose ingestion in healthy humans

Individuals with certain MC4R genotypes may experience a weaker subjective appetite reduction from the same GLP-1 dose not because the medication isn't working pharmacologically, but because the downstream receptor response is genetically attenuated

(Online Resource 1)

This makes oral administration viable, particularly for gastrointestinal applications where the peptide can act locally on the gut lining

Tailoring treatments to individual characteristics enhances the precision and success of fat dissolving injections

Synopsis GLP-1 drugs lead to a loss of body mass, including as much as 40% lean mass, which includes muscle